Economic Evaluations of Varicella Vaccination Programmes

[1]  P. Reinert,et al.  Varicella vaccine , 2004, Medecine et maladies infectieuses.

[2]  J. Caro,et al.  Instituting a routine varicella vaccination program in Canada: an economic evaluation , 2002, The Pediatric infectious disease journal.

[3]  W. Edmunds,et al.  The cost-effectiveness of varicella vaccination in Canada. , 2002, Vaccine.

[4]  H. Glick,et al.  Economic evaluation of vaccination programmes: a consensus statement focusing on viral hepatitis. , 2002, PharmacoEconomics.

[5]  Jan B Oostenbrink,et al.  Standardisation of costs: the Dutch Manual for Costing in economic evaluations. , 2002, PharmacoEconomics.

[6]  Conjugate Meningococcal.  An advisory committee statement (ACS). National Advisory Committee on Immunization (NACI). NACI update to statement on varicella vaccine. , 2002, Canada communicable disease report = Releve des maladies transmissibles au Canada.

[7]  P. Beutels.  Economic evaluations of hepatitis B immunization: a global review of recent studies (1994-2000). , 2001, Health economics.

[8]  E. Shapiro,et al.  The effectiveness of the varicella vaccine in clinical practice. , 2001, The New England journal of medicine.

[9]  R. J. Harman,et al.  National Institute for clinical excellence preoperative tests: Is the consensus hard to get?: 1AP3-9 , 2007 .

[10]  W. Edmunds,et al.  Modelling the impact of immunization on the epidemiology of varicella zoster virus , 2000, Epidemiology and Infection.

[11]  W. P. Stephenson,et al.  The postmarketing safety profile of varicella vaccine. , 2000, Vaccine.

[12]  M. Braun,et al.  Postlicensure safety surveillance for varicella vaccine. , 2000, JAMA.

[13]  G. Moens,et al.  Occupational risk of infection by varicella zoster virus in Belgian healthcare workers: a seroprevalence study , 2000, Occupational and environmental medicine.

[14]  M. Wharton,et al.  Varicella mortality: trends before vaccine licensure in the United States, 1970-1994. , 2000, The Journal of infectious diseases.

[15]  Kenneth J. Smith,et al.  Cost effectiveness of vaccination strategies in adults without a history of chickenpox. , 2000, The American journal of medicine.

[16]  W. Edmunds,et al.  Analysis of varicella vaccine breakthrough rates: implications for the effectiveness of immunisation programmes. , 2000, Vaccine.

[17]  M. R. Howell,et al.  The cost-effectiveness of varicella screening and vaccination in U.S. Army recruits. , 2000, Military medicine.

[18]  D. Klinman,et al.  Varicella vaccination: Evidence for frequent reactivation of the vaccine strain in healthy children , 2000, Nature Medicine.

[19]  E. Doorslaer,et al.  Program evaluation of universal varicella vaccination in Belgium: preliminary results , 2000 .

[20]  D J Nokes,et al.  Evaluating the cost-effectiveness of vaccination programmes: a dynamic perspective. , 1999, Statistics in medicine.

[21]  E. Walter,et al.  Postlicensure study of varicella vaccine effectiveness in a day-care setting. , 1999, The Pediatric infectious disease journal.

[22]  P. Scuffham,et al.  The cost-effectiveness of varicella vaccine programs for Australia. , 1999, Vaccine.

[23]  M. Johannesson,et al.  Inconsistencies in the "Societal Perspective" on Costs of the Panel on Cost-Effectiveness in Health and Medicine , 1999, Medical decision making : an international journal of the Society for Medical Decision Making.

[24]  P. Scuffham,et al.  The cost-effectiveness of introducing a varicella vaccine to the New Zealand immunisation schedule. , 1999, Social science & medicine.

[25]  U. Buchholz,et al.  Varicella Outbreaks After Vaccine Licensure: Should They Make You Chicken? , 1999, Pediatrics.

[26]  S. Straus,et al.  Epinephrine and outcome after cardiac arrest. , 1999, Annals of internal medicine.

[27]  P. Brunell,et al.  Varicella Serological Status of Healthcare Workers as a Guide to Whom to Test or Immunize , 1999, Infection Control & Hospital Epidemiology.

[28]  J. Latour,et al.  A cost benefit analysis of routine varicella vaccination in Spain. , 1999, Vaccine.

[29]  L. Coudeville,et al.  The value of varicella vaccination in healthy children: cost-benefit analysis of the situation in France. , 1999, Vaccine.

[30]  J. Gayman.  A cost-effectiveness model for analyzing two varicella vaccination strategies. , 1998, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists.

[31]  Ben A. van Hout,et al.  Discounting costs and effects: a reconsideration. , 1998 .

[32]  T. Koepsell,et al.  Prevention of Chickenpox in Reproductive‐Age Women: Cost‐Effectiveness of Routine Prenatal Screening With Postpartum Vaccination of Susceptibles , 1998, Obstetrics and gynecology.

[33]  J. Riddle,et al.  A cost-benefit analysis of a routine varicella vaccination program for United States Air Force Academy cadets. , 1998, Military medicine.

[34]  A. Mushlin,et al.  Cost‐Effectiveness of Routine Antenatal Varicella Screening , 1998, Obstetrics and gynecology.

[35]  N. Adler,et al.  Varicella serology among school age children with a negative or uncertain history of chickenpox. , 1998, The Pediatric Infectious Disease Journal.

[36]  D. Nathwani,et al.  Varicella infections in pregnancy and the newborn. A review prepared for the UK Advisory Group on Chickenpox on behalf of the British Society for the Study of Infection. , 1998, The Journal of infection.

[37]  B. van Hout.  Discounting costs and effects: a reconsideration. , 1998, Health economics.

[38]  P. Strebel,et al.  Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center. , 1997, JAMA.

[39]  A. Gray,et al.  An economic analysis of varicella vaccination for health care workers , 1997, Epidemiology and Infection.

[40]  M. Nettleman,et al.  Controlling Varicella in the Healthcare Setting: The Cost Effectiveness of Using Varicella Vaccine in Healthcare Workers , 1997, Infection Control & Hospital Epidemiology.

[41]  A. Tennenberg,et al.  Varicella Vaccination for Healthcare Workers at a University Hospital An Analysis of Costs and Benefits , 1997, Infection Control & Hospital Epidemiology.

[42]  B. Yawn,et al.  Community impact of childhood varicella infections. , 1997, The Journal of pediatrics.

[43]  M. Koopmanschap,et al.  Productivity costs measurement through quality of life? A response to the recommendation of the Washington Panel. , 1997, Health economics.

[44]  P. Keller,et al.  Measles, mumps, rubella, and varicella combination vaccine: safety and immunogenicity alone and in combination with other vaccines given to children. Measles, Mumps, Rubella, Varicella Vaccine Study Group. , 1997, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[45]  M. Gold.  Cost-effectiveness in health and medicine , 2016 .

[46]  P. van Damme,et al.  Costs and benefits of routine varicella vaccination in German children. , 1996, The Journal of infectious diseases.

[47]  C. Fairley,et al.  Varicella-zoster virus epidemiology--a changing scene? , 1996, The Journal of infectious diseases.

[48]  D. Stevenson,et al.  Varicella vaccine in pregnancy , 1996, BMJ.

[49]  M E Halloran,et al.  Epidemiologic effects of varicella vaccination. , 1996, Infectious disease clinics of North America.

[50]  B. Cryan,et al.  Susceptibility to varicella zoster virus infection in health care workers. , 1996, Occupational medicine.

[51]  Frank A. Sloan,et al.  Valuing health care , 1996 .

[52]  D. Rouse,et al.  Management of the Presumed Susceptible Varicella (Chickenpox)‐Exposed Gravida: A Cost‐Effectiveness/Cost‐Benefit Analysis , 1996, Obstetrics and gynecology.

[53]  V Demicheli,et al.  An exercise on the feasibility of carrying out secondary economic analyses. , 1996, Health economics.

[54]  M A Koopmanschap,et al.  The friction cost method for measuring indirect costs of disease. , 1995, Journal of health economics.

[55]  T. Lieu,et al.  Cost-effectiveness of varicella serotesting versus presumptive vaccination of school-age children and adolescents. , 1995, Pediatrics.

[56]  Milton C. Weinstein,et al.  Valuing health care: From cost–effectiveness ratios to resource allocation: where to draw the line? , 1995 .

[57]  M. Pauly.  Valuing health care: Valuing health care benefits in money terms , 1995 .

[58]  M E Halloran,et al.  Theoretical epidemiologic and morbidity effects of routine varicella immunization of preschool children in the United States. , 1994, American journal of epidemiology.

[59]  G. Oster,et al.  Childhood vaccination against chickenpox: an analysis of benefits and costs. , 1994, The Journal of pediatrics.

[60]  M. Halloran,et al.  Cost-effectiveness of a routine varicella vaccination program for US children. , 1994, JAMA.

[61]  A. Gafni,et al.  An economic evaluation of varicella vaccine for pediatric liver and kidney transplant recipients. , 1993, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[62]  G. Mooney,et al.  QALY league tables: handle with care. , 1993, Health economics.

[63]  B. Grenfell,et al.  The epidemiology of varicella–zoster virus infections: the influence of varicella on the prevalence of herpes zoster , 1992, Epidemiology and Infection.

[64]  M. Parsonage,et al.  Discounting and health benefits. , 1992, Health economics.

[65]  P. Robertson,et al.  Determination and importance of varicella immune status of nursing staff in a children's hospital. , 1990, The Journal of hospital infection.

[66]  S. Wilson.  Methods for the economic evaluation of health care programmes , 1987 .

[67]  B. Squires.  Methods for the Economic Evaluation of Health Care Programmes. , 1987 .

[68]  S. Preblud.  Varicella: complications and costs. , 1986, Pediatrics.

[69]  B. Levine,et al.  Combination measles, mumps, rubella and varicella vaccine. , 1986, Pediatrics.

[70]  A. Hinman,et al.  A benefit-cost analysis of a childhood varicella vaccination programme. , 1985, Postgraduate medical journal.

[71]  E. Scolnick,et al.  Live attenuated varicella virus vaccine. Efficacy trial in healthy children. , 1984, The New England journal of medicine.

[72]  E. Keeler,et al.  Discounting of Life-Saving and Other Nonmonetary Effects , 1983 .

[73]  S. Finkler.  The distinction between cost and charges. , 1982, Annals of internal medicine.

[74]  M. Weinstein,et al.  Foundations of cost-effectiveness analysis for health and medical practices. , 1977, The New England journal of medicine.

[75]  Y. Okuno,et al.  Live vaccine used to prevent the spread of varicella in children in hospital. , 1974, Lancet.